Sugammadex, a modified γ-cyclodextrin, is the first selective relaxant binding agent. Sugammadex forms very tight complexes in a 1:1 ratio with steroidal neuromuscular blocking agents (rocuronium ...

Sugammadex effectively reverses neuromuscular blockade in myasthenia gravis patients, ensuring rapid recovery and minimal complications. The review of 24 studies with 1679 patients showed no ...

The use of rocuronium and sugammadex for reversing neuromuscular blockade increased dramatically over 6 years in patients with moderate and severe renal impairment. The variation in strategy ...

Venus Remedies Limited, a leading Indian manufacturer of injectable drugs, has received its first ever global marketing authorization for Sugammadex from the Philippines. This approval marks a major ...